
Biocartesian combines chemistry and microscopy to provide advanced tissue profiling, data visualization, and high-throughput cell culture solutions. Their innovative approach allows for detailed analysis of DNA, RNA, and proteins in biological specimens, utilizing AI-powered tools for automated data analysis. This positions them uniquely in the market, catering to clients seeking comprehensive biological insights and enhancing research capabilities.

Biocartesian combines chemistry and microscopy to provide advanced tissue profiling, data visualization, and high-throughput cell culture solutions. Their innovative approach allows for detailed analysis of DNA, RNA, and proteins in biological specimens, utilizing AI-powered tools for automated data analysis. This positions them uniquely in the market, catering to clients seeking comprehensive biological insights and enhancing research capabilities.
Headquarters: San Francisco, United States
Founded: 2023
Focus: High-plex tissue molecular profiling (DNA, RNA, protein) combining chemistry, microscopy, and AI
Investors: Y Combinator
Employees (approx.): 4
Molecular tissue analysis and spatial biology for research institutions and labs
2023
Biotechnology
Pre-Seed round announced; some sources report an associated seed entry tied to Y Combinator (YC S24).
“Y Combinator; angel investor(s) reported including Goran Gohring”